119 related articles for article (PubMed ID: 35263809)
1. Head-to-head comparison of a risk-adapted screening strategy using various risk prediction models in detecting colorectal neoplasm.
Lu M; Zhang Y; Cai J; Lu B; Luo C; Chen H; Dai M
J Gastroenterol Hepatol; 2022 Jul; 37(7):1244-1252. PubMed ID: 35263809
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C).
Chen H; Shi J; Lu M; Li Y; Du L; Liao X; Wei D; Dong D; Gao Y; Zhu C; Ying R; Zheng W; Yan S; Xiao H; Zhang J; Kong Y; Li F; Zou S; Liu C; Wang H; Zhang Y; Lu B; Luo C; Cai J; Tian J; Miao X; Ding K; Brenner H; Dai M
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):808-818. PubMed ID: 35964896
[TBL] [Abstract][Full Text] [Related]
3. Optimizing Positivity Thresholds for a Risk-Adapted Screening Strategy in Colorectal Cancer Screening.
Lu M; Wang L; Zhang Y; Liu C; Lu B; Du L; Liao X; Dong D; Wei D; Gao Y; Shi J; Ren J; Chen H; Dai M
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00398. PubMed ID: 34397041
[TBL] [Abstract][Full Text] [Related]
4. Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C).
Chen H; Lu M; Liu C; Zou S; Du L; Liao X; Dong D; Wei D; Gao Y; Zhu C; Zhu L; Zheng W; Xiao H; Kong Y; Yin H; Zhou H; Ying R; Wang B; Zhang J; Zhang X; Zhang Q; Zhang X; Zhang Y; Wang H; Guo L; Liu L; Ren J; Shi J; Li N; Miao X; Brenner H; Dai M
Am J Gastroenterol; 2020 Aug; 115(8):1264-1274. PubMed ID: 32282342
[TBL] [Abstract][Full Text] [Related]
5. Risk Stratification Score Improves Sensitivity for Advanced Colorectal Neoplasia in Colorectal Cancer Screening: The Oshima Study Workgroup.
Sekiguchi M; Kakugawa Y; Ikematsu H; Hotta K; Konda K; Tanaka Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Imai K; Ito S; Koga Y; Iwasaki M; Murakami Y; Matsuda T
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00319. PubMed ID: 33939384
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824
[No Abstract] [Full Text] [Related]
7. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg FG; Vleugels JL; de Wijkerslooth TR; Stegeman I; Stoop EM; van Leerdam ME; Kuipers EJ; Bossuyt PM; Dekker E
Aliment Pharmacol Ther; 2016 Jul; 44(1):88-96. PubMed ID: 27170502
[TBL] [Abstract][Full Text] [Related]
8. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparison of the test performance of self-administered qualitative vs. laboratory-based quantitative fecal immunochemical tests in detecting colorectal neoplasm.
Lu M; Zhang YH; Lu B; Cai J; Liu CC; Chen HD; Dai M
Chin Med J (Engl); 2021 May; 134(11):1335-1344. PubMed ID: 34039863
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score.
Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
J Gastroenterol Hepatol; 2020 Sep; 35(9):1555-1561. PubMed ID: 32167186
[TBL] [Abstract][Full Text] [Related]
11. [Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].
Chen HD; Lu M; Liu CC; Zhang YH; Zou SM; Shi JF; Ren JS; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Oct; 41(10):1655-1661. PubMed ID: 33297622
[No Abstract] [Full Text] [Related]
12. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
[TBL] [Abstract][Full Text] [Related]
13. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
[TBL] [Abstract][Full Text] [Related]
14. One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).
Wong G; Hope RL; Howard K; Chapman JR; Castells A; Roger SD; Bourke MJ; Macaskill P; Turner R; Williams G; Lim WH; Lok CE; Diekmann F; Cross NB; Sen S; Allen RDM; Chadban SJ; Pollock CA; Tong A; Teixeira-Pinto A; Yang JYH; Williams N; Au EHK; Kieu A; James L; Craig JC
J Am Soc Nephrol; 2019 Jun; 30(6):1061-1072. PubMed ID: 31040191
[TBL] [Abstract][Full Text] [Related]
15. Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016.
Almansoori A; Alzaabi M; Alketbi L
BMC Cancer; 2021 Aug; 21(1):897. PubMed ID: 34362343
[TBL] [Abstract][Full Text] [Related]
16. Identifying the optimal strategy for screening of advanced colorectal neoplasia.
Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
J Gastroenterol Hepatol; 2017 May; 32(5):1003-1010. PubMed ID: 28449340
[TBL] [Abstract][Full Text] [Related]
17. Towards risk-stratified colorectal cancer screening. Adding risk factors to the fecal immunochemical test: Evidence, evolution and expectations.
van de Veerdonk W; Hoeck S; Peeters M; Van Hal G
Prev Med; 2019 Sep; 126():105746. PubMed ID: 31173802
[TBL] [Abstract][Full Text] [Related]
18. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
19. Gender-specific cut-off levels in colorectal cancer screening with fecal immunochemical test: A population-based study of colonoscopy findings and costs.
Ribbing Wilén H; Saraste D; Blom J
J Med Screen; 2021 Dec; 28(4):439-447. PubMed ID: 34106777
[TBL] [Abstract][Full Text] [Related]
20. Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test.
He XX; Yuan SY; Li WB; Yang H; Ji W; Wang ZQ; Hao JY; Chen C; Chen WQ; Gao YX; Li LB; Cheng KL; Qian JM; Wang L; Li JN
BMC Gastroenterol; 2019 Dec; 19(1):226. PubMed ID: 31881948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
